Results 191 to 200 of about 100,051 (354)

Rare but relevant: Hydrocarbons and sudden sniffing syndrome

open access: yesAddiction, EarlyView.
Abstract Inhaled hydrocarbon‐associated sudden collapse (IHASC), often referred to as ‘sudden sniffing death syndrome’ is a critical and often fatal event linked to the inhalation of volatile hydrocarbons, primarily occurring in adolescents and young adults. This syndrome manifests as sudden cardiac and/or respiratory arrest, typically occurring during
Ingrid Berling   +1 more
wiley   +1 more source

Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)

open access: yesAddiction, EarlyView.
Abstract Background and Aims In 2024, cannabis was partially legalized for recreational purposes in Germany. With a growing prevalence of persons who used cannabis in the past 12 months, and the health risks associated with cannabis use, it is imperative to examine usage behavior patterns in greater detail.
Natalie S. Schöllner   +5 more
wiley   +1 more source

Synthetic cannabinoids in e‐cigarettes seized from English schools

open access: yesAddiction, EarlyView.
Abstract Background and aims People who use synthetic cannabinoids (SCs) report debilitating side effects and withdrawal symptoms, coupled with dependence. In the UK, SC use was believed to be largely restricted to prison, where they are the most common drug and associated with nearly half of non‐natural deaths, or poly‐drug users in the community who ...
Gyles E. Cozier   +17 more
wiley   +1 more source

Do psychotropic drugs cause seizures? [PDF]

open access: yesEpilepsy Behav Rep
Gopaul M, Altalib H.
europepmc   +1 more source

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage   +3 more
wiley   +1 more source

Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background and Objectives Several medications for alcohol use disorder (MAUDs) are recommended to treat alcohol use disorder (AUD) in the Veterans Affairs (VA) guidelines. This study descriptively characterized treatment patterns and healthcare resource utilization (HCRU) among VA patients with AUD treated with VA‐recommended MAUDs.
Regina Grebla   +13 more
wiley   +1 more source

The impact of using cannabis during pregnancy on the infant and mother: An overview of systematic reviews, evidence map, targeted updates, and de novo synthesis

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
Background Cannabis use during pregnancy is becoming more prevalent. While numerous studies have explored the relationship of cannabis use during pregnancy and outcomes for mothers and infants, uncertainty remains regarding the impact of cannabis use on pregnancy complications and later‐life outcomes for offspring.
Zachary Munn   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy